Sort by
Refine Your Search
-
. Gomez-Lopez’s research is primarily focused on the immunological pathways that lead to obstetrical disorders, with the goals of improving the understanding of the mechanisms of disease and of developing
-
. The lab focuses on generating and utilizing pluripotent stem cell and primate models to dissect the cellular and molecular mechanisms of embryogenesis and investigate reproductive complications, including
-
interdisciplinary role will focus on investigating mechanisms of treatment resistance in gastrointestinal cancers, with a specific emphasis on pancreatic neuroendocrine and biliary tract cancers and exploring
-
the mechanisms and conditions driving the evolution of biological diversity, with a focus on animal behavior. This position will provide an excellent opportunity for the successful candidate to perform research
-
Lab is focused on understanding the homeostasis of lung vascular biology and pathogenesis of cardiopulmonary diseases with the goals of 1) understanding underlying mechanisms of pulmonary vascular
-
dedicated to understanding the molecular mechanisms of ATP-dependent AAA+ proteolytic machines in both bacterial systems and human mitochondria, exploring how these complexes form and achieve substrate
-
mechanisms and disease outcomes. This work involves a multidisciplinary approach, including next-generation sequencing, bacterial genetics, host genetics and metabolomics. Job Description Primary Duties
-
Position Summary We are seeking a highly motivated Postdoctoral Research Associate to join our lab at WashU Medicine. Our group has studied the mechanisms mediating thromboinflammatory diseases
-
mechanisms and competitive external fellowships. The postdoctoral scholar is strongly encouraged to apply for independent funding during their training and will be given support and mentorship in this effort
-
Position Summary The Foltz lab works at the intersection of translational immunology and computational biology. We study mechanisms of response and resistance to natural killer (NK) cell therapies